Case Studies in Chemical and Environmental Engineering,
Journal Year:
2021,
Volume and Issue:
4, P. 100127 - 100127
Published: Aug. 30, 2021
During
the
last
decades,
growth
of
concern
towards
different
pollutants
has
been
increasing
due
to
population
activities
in
large
cities
and
great
need
for
food
production
by
agri-food
industry.
The
effects
observed
specific
locations
have
shown
impact
over
environment
air,
soil
water.
Specifically,
current
pandemic
COVID-19
brought
into
picture
intensive
use
medical
substances
treat
disease
misuse.
In
particular,
antibiotics
increased
during
20
years
with
few
regulations
regarding
their
excessive
disposal
residues
from
sources.
Within
this
review,
an
overview
sources
aquatic
environments
was
done
along
its
trophic
chain,
negative
human
health
prolonged
exposure
which
endanger
environment,
health,
water,
sustainability.
revision
indicates
differences
between
potential
danger
toxicity,
accumulation
that
prevents
water
sustainability
long
run.
Infection,
Journal Year:
2021,
Volume and Issue:
49(5), P. 935 - 943
Published: May 22, 2021
Coronavirus
disease
2019
(COVID-19)
caused
by
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
has
spread
around
the
world.
Differentiation
between
pure
viral
COVID-19
pneumonia
and
secondary
infection
can
be
challenging.
In
patients
with
elevated
C-reactive
protein
(CRP)
on
admission
physicians
often
decide
to
prescribe
antibiotic
therapy.
However,
overuse
of
anti-infective
therapy
in
pandemic
should
avoided
prevent
increasing
antimicrobial
resistance.
Procalcitonin
(PCT)
CRP
have
proven
useful
other
lower
tract
infections
might
help
differentiate
or
infection.We
performed
a
retrospective
study
admitted
6th
March
30th
October
2020.
Patient
background,
clinical
course,
laboratory
findings
focus
PCT
levels
microbiology
results
were
evaluated.
Patients
without
bacterial
relation
compared.
Using
receiver
operating
characteristic
(ROC)
analysis,
best
discriminating
cut-off
value
corresponding
sensitivity
specificity
was
calculated.Out
99
inpatients
(52
ICU,
47
Non-ICU)
COVID-19,
32
(32%)
presented
during
hospitalization.
had
higher
(0.4
versus
0.1
ng/mL;
p
=
0.016)
(131
73
mg/L;
0.001)
at
hospital
stay
(2.9
<
0.001
resp.
293
94
0.001).
The
majority
general
ward
no
(93%).
More
than
half
ICU
developed
(56%).
ROC
analysis
highest
yielded
AUCs
0.88
(p
0.86
for
entire
cohort.
With
0.55
ng/mL,
91%
81%;
172
mg/L
81%
76%.PCT
measurement
course
may
helpful
identifying
guiding
use
